Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -554.01% is 15% below its 5-year average of -482.49%, around the middle of its 5-year range (-832.49%–-134.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.57% above its 12-month average of -592.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -554.01%.
RETURN ON EQUITY (ROE)
-554.01%
RETURN ON EQUITY (ROE) AVG TTM
-592.97%
RETURN ON EQUITY (ROE) AVG 3Y
-517.13%
RETURN ON EQUITY (ROE) AVG 5Y
-482.49%
RETURN ON EQUITY (ROE) AVG 10Y
-419.03%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.57%
CURRENT VS 3Y AVG
-7.13%
CURRENT VS 5Y AVG
-14.82%
CURRENT VS 10Y AVG
-32.21%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.15%
median of 712 covered companies
CURRENT VS SECTOR MEDIAN
-1246.33%
vs the sector median at left
Jaguar Health, Inc.
Market Cap
$2.49M
Return on Equity (ROE)
-554.01%
TTM Avg
-592.97%
3Y Avg
-517.13%
5Y Avg
-482.49%
Market Cap
$2.54M
Return on Equity (ROE)
-391.26%
TTM Avg
-355.49%
3Y Avg
-474.62%
5Y Avg
-295.97%
Market Cap
$2.41M
Return on Equity (ROE)
-261.73%
TTM Avg
-293.81%
3Y Avg
-189.35%
5Y Avg
-145.76%
Market Cap
$2.55M
Return on Equity (ROE)
-402.92%
TTM Avg
-276.14%
3Y Avg
-197.40%
5Y Avg
-116.89%
Market Cap
$2.37M
Return on Equity (ROE)
-75.70%
TTM Avg
-349.85%
3Y Avg
-22.96%
5Y Avg
-60.31%
Market Cap
$2.37M
Return on Equity (ROE)
-53.49%
TTM Avg
-904.74%
3Y Avg
-509.27%
5Y Avg
-319.78%
Market Cap
$2.62M
Return on Equity (ROE)
N/A
TTM Avg
-419.35%
3Y Avg
-396.40%
5Y Avg
-293.00%
Market Cap
$2.31M
Return on Equity (ROE)
-69.79%
TTM Avg
-83.20%
3Y Avg
-70.37%
5Y Avg
-0.36%
Market Cap
$2.73M
Return on Equity (ROE)
-657.69%
TTM Avg
-358.53%
3Y Avg
-220.37%
5Y Avg
-149.08%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.49M | -554.01% | -592.97% | -517.13% | -482.49% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | -391.26% | -355.49% | -474.62% | -295.97% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.41M | -261.73% | -293.81% | -189.35% | -145.76% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | -402.92% | -276.14% | -197.40% | -116.89% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -75.70% | -349.85% | -22.96% | -60.31% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.37M | -53.49% | -904.74% | -509.27% | -319.78% |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | N/A | -419.35% | -396.40% | -293.00% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.31M | -69.79% | -83.20% | -70.37% | -0.36% |
| iSpecimen Inc. (ISPC)vs › | $2.73M | -657.69% | -358.53% | -220.37% | -149.08% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.07M | -1160.10% | -528.10% | -389.86% | -336.02% |
ROE
-554.0%
ROA
-107.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -554.01% |
| 2025-09-30 | -716.07% |
| 2025-06-30 | -508.83% |
| 2024-12-31 | -528.37% |
| 2024-09-30 | -277.27% |
| 2024-06-30 | -183.93% |
| 2024-03-31 | -264.61% |
| 2023-12-31 | -832.49% |
| 2023-06-30 | -788.59% |
| 2023-03-31 | -566.94% |
| 2022-03-31 | -728.05% |
| 2021-12-31 | -452.98% |
| 2021-09-30 | -218.31% |
| 2021-06-30 | -134.42% |
| 2021-03-31 | -118.79% |
| 2020-12-31 | -196.54% |
| 2020-09-30 | -397.12% |
| 2020-03-31 | -612.41% |
| 2019-12-31 | -361.09% |
| 2019-09-30 | -221.95% |
| 2019-06-30 | -595.67% |
| 2019-03-31 | -511.39% |
| 2018-12-31 | -597.16% |
| 2018-09-30 | -384.52% |
| 2018-06-30 | -205.46% |
| 2018-03-31 | -109.25% |
| 2017-12-31 | -127.27% |
| 2017-09-30 | -17.09% |
| 2016-06-30 | -941.23% |
| 2016-03-31 | -351.47% |
| 2015-12-31 | -370.34% |
| 2015-09-30 | -168.90% |
| 2015-06-30 | -125.07% |
| 2014-12-31 | -785.38% |
